MEDP Medpace Corp: Net earnings per share for the last four quarters

Medpace Holdings (MEDP) - corporate logo

Profit growth for Medpace Holdings, Inc. (MEDP) relies on the indispensability of IT infrastructure for small biotechs and the influx of new drugs. The 12-month YoY EPS growth rates visualize this trend, where 25.50 captures the current value of the indicator. While strict FDA regulations and scientific expertise ensure stability, labor shortages and client financial risks may constrain business margins.

MEDP (Medpace) Earnings per share for the last twelve months history from 02/11/2024 to 11/18/2026

Medpace Holdings - analytical breakdowns and key metrics (MEDP)

- price and consensus price forecast:
Fundamental company valuation:Medpace Holdings, MEDP
Manufactured product of Medpace

The neutral geopolitical status of Medpace Holdings, Inc. (MEDP) within the clinical research sector minimizes external risks, ensuring stable cash flows. This is reflected in the EPS TTM trend, which measures the percentage change in net income per share over the last twelve months. This metric allows for an assessment of the real efficiency of business scaling and the pace of profit generation. Analyzing the historical annual dynamics of EPS TTM helps determine the market revaluation of the asset relative to industry standards.